Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Direxion Daily Semiconductor Bear 3X Shares (SOXS) vs Vertex Pharmaceuticals Incorporated (VRTX) Price & Performance

Direxion Daily Semiconductor Bear 3X SharesTrade
Vertex Pharmaceuticals IncorporatedTrade

Price performance (Past 24H)

Key statistics

Direxion Daily Semiconductor Bear 3X Shares vs Vertex Pharmaceuticals Incorporated — how do they compare? Direxion Daily Semiconductor Bear 3X Shares trades at $41.51, while Vertex Pharmaceuticals Incorporated trades at $529.98 (market cap $134.25B). Which is the better fit depends on your goals.

SOXSVRTX
Sector
Leveraged / InverseHealth
52-Week High
$1.49K$529.65
52-Week Low
$32.50$376.62
Market Cap
$134.25B
Enterprise Value
$128.37B

Returns comparison

Trailing returns across standard periods

About Direxion Daily Semiconductor Bear 3X Shares

SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.

Read more on SOXS

About Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Read more on VRTX